Literature DB >> 5906371

Influence of penicillinase-producing staphylococci on the eradication of group A streptococci from the upper respiratory tract by penicillin treatment.

P G Quie, H C Pierce, L W Wannamaker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5906371

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  8 in total

1.  Lincomycin in commonly encountered infections.

Authors:  S S Guslits
Journal:  Can Fam Physician       Date:  1968-09       Impact factor: 3.275

Review 2.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1967-03       Impact factor: 2.401

Review 3.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Authors:  Rob J L Willems; William P Hanage; Debra E Bessen; Edward J Feil
Journal:  FEMS Microbiol Rev       Date:  2011-07-04       Impact factor: 16.408

4.  Clindamycin, a new antibiotic in otolaryngological infections.

Authors:  M C Gyde
Journal:  Can Fam Physician       Date:  1970-08       Impact factor: 3.275

5.  β-Lactamase-Producing Bacteria in Upper Respiratory Tract Infections.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2010-03       Impact factor: 3.725

6.  The extended microbiology of group A streptococcal pharyngitis. Observations during a double-blind controlled study of cephalexin twice versus four-times daily.

Authors:  M M Tarpay; S Chartrand; M Marks; A Cox
Journal:  Infection       Date:  1984 May-Jun       Impact factor: 3.553

7.  Cefadroxil versus penicillin in the treatment of streptococcal tonsillopharyngitis.

Authors:  D Milatovic; J Knauer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

8.  Direct and indirect pathogenicity of Branhamella catarrhalis.

Authors:  I Brook
Journal:  Drugs       Date:  1986       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.